- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 31/4174 - Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
Patent holdings for IPC class A61K 31/4174
Total number of patents in this class: 950
10-year publication summary
|
75
|
71
|
66
|
79
|
87
|
76
|
73
|
70
|
61
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Allergan, Inc. | 2310 |
51 |
| Bioxcel Therapeutics, Inc. | 83 |
51 |
| Clexio Biosciences Ltd. | 102 |
11 |
| Allergan Holdings Unlimited Company | 37 |
10 |
| The Rockefeller University | 582 |
10 |
| Bristol-myers Squibb Company | 4793 |
9 |
| Hisamitsu Pharmaceutical Co., Inc. | 782 |
9 |
| F. Hoffmann-La Roche AG | 7895 |
8 |
| The Regents of the University of California | 20315 |
8 |
| EPI Health, LLC | 11 |
8 |
| Case Western Reserve University | 1856 |
7 |
| Galderma Research & Development | 379 |
7 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3361 |
7 |
| Mitobridge, Inc. | 34 |
7 |
| Orion Corporation | 712 |
7 |
| ARx, LLC | 25 |
6 |
| Cmpd Licensing, LLC | 81 |
6 |
| Mayne Pharma LLC | 55 |
6 |
| Nicox Ophthalmics, Inc. | 23 |
6 |
| Newmarket Pharmaceuticals LLC | 13 |
6 |
| Other owners | 710 |